Table 3.
In vitro enzyme‐linked immunospot assay before the initiation of therapy and after two cycles of treatment in the HLA‐A2402 unmatched group
| No. | CTL Response (RNF43/TOMM34) | ||
|---|---|---|---|
| Before the initiation of therapy | After 2 cycles of therapy | Assessment | |
| 1 | NA/NA | NA/NA | Not assessed |
| 2 | −/− | +/+ | Positive |
| 3 | −/− | +/− | Positive |
| 4 | +/− | ++/+ | Positive |
| 5 | −/− | NA/− | Not assessed |
| 6 | −/− | +/+ | Positive |
| 7 | NA/NA | −/− | Negative |
| 8 | −/− | −/+ | Positive |
| 9 | +/− | −/+ | Positive |
| 10 | −/− | −/− | Negative |
| 11 | −/+ | +/+ | Positive |
| 12 | +/− | −/+ | Positive |
| 13 | −/− | −/+ | Positive |
| 14 | −/− | NA/NA | Not assessed |
| 15 | −/NA | +/− | Positive |
| 16 | −/NA | NA/NA | Not assessed |
NA, not available.